XML 19 R8.htm IDEA: XBRL DOCUMENT v3.26.3
Unaudited Condensed Statements of Cash Flows - USD ($)
4 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2026
Cash Flows from Operating Activities:    
Net income $ 470,519 $ 7,109,406
Adjustments to reconcile net income to net cash used in operating activities:    
Payment of operation costs through IPO Promissory Note 17,420
Interest earned on marketable securities held in Trust Account (576,612) (7,518,330)
Changes in operating assets and liabilities:    
Prepaid expenses (20,483) (9,918)
Prepaid insurance (136,172) 52,523
Accrued expenses 3,333 (2,917)
Accrued expenses – related party 6,667 90,000
Net cash used in operating activities (235,328) (279,236)
Cash Flows from Investing Activities:    
Investment of cash into Trust Account (275,000,000)
Net cash used in investing activities (275,000,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 270,200,000
Proceeds from sale of Private Placement Warrants 6,800,000
Repayment of IPO Promissory Note – related party (170,256)
Payment of offering costs (328,044)
Net cash provided by financing activities 276,501,700
Net Change in Cash and Cash Equivalents 1,266,372 (279,236)
Cash and cash equivalents – Beginning of period 1,186,244
Cash and cash equivalents – End of period 1,266,372 907,008
Noncash investing and financing activities:    
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares 25,000
Deferred offering costs included in accrued offering expenses 75,000
Deferred offering costs paid through IPO Promissory Note – related party 152,836
Deferred underwriting fee payable $ 11,700,000